sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Sep-2014 11:51
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 726-750 out of 888.

<< < 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 > >>

Public Release: 13-Feb-2013
Tuberculosis and neglected diseases targeted by new center
A major new center to boost the development of drugs to tackle the foremost diseases of the developing world is to be created at the University of Dundee. The Centre is being established with joint funding from the Wellcome Trust and the Bill & Melinda Gates Foundation.
Wellcome Trust, Bill & Melinda Gates Foundation

Contact: Roddy Isles
University of Dundee

Public Release: 12-Feb-2013
Journal of American Chemical Society
Detecting cocaine 'naturally'
Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening -- less than five minutes -- of many drugs, infectious diseases, and cancers.
Italian Ministry of University and Research, Bill & Melinda Gates Foundation, and others

Contact: Julie Gazaille
University of Montreal

Public Release: 12-Feb-2013
24th Annual Conference of the Saudi Heart Association
CVD time bomb set to explode in Gulf region in 10-15 years
With one of the highest rates of obesity in the world, the Gulf region is facing an epidemic of cardiovascular disease. The Saudi Project for Assessment of Acute Coronary Syndrome found that 58 percent of the 5055 acute coronary syndrome patients in the study had diabetes.

Contact: Jacqueline Partarrieu
European Society of Cardiology

Public Release: 12-Feb-2013
PLOS Medicine
More evidence needed for scale up of mobile device technology in health
Despite the hundreds of pilot studies using mobile health -- also known as 'mHealth'', which describe medical and public health practice supported by mobile devices -- there is insufficient evidence to inform the widespread implementation and scale-up of this technology, according to international researchers writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 12-Feb-2013
Study examines malaria preventive therapy during pregnancy and outcomes for infants in Africa
Among pregnant women in sub-Saharan Africa, intermittent preventive therapy for malaria with 3 or more doses of the drug regimen sulfadoxine-pyrimethamine was associated with a higher birth weight and lower risk of low birth weight than the current standard 2-dose regimen, according to a review and meta-analysis of previous studies published in the Feb. 13 issue of JAMA.

Contact: Feiko O. ter Kuile
The JAMA Network Journals

Public Release: 11-Feb-2013
Diabetes Care
Community health workers help type 2 diabetes care
Researchers who conducted a clinical trial in American Samoa to test whether community health workers could help adults with type 2 diabetes found that the patients who received the intervention were twice as likely to make a clinically meaningful improvement as those who remained with care only in the clinic. The results appear in the journal Diabetes Care.
NIH/National Institute of Diabetes and Digestive and Kidney Disorders

Contact: David Orenstein
Brown University

Public Release: 11-Feb-2013
Proceedings of the National Academy of Sciences
Unchecked antibiotic use in animals may affect global human health
The increasing production and use of antibiotics, about half of which is used in animal production, is mirrored by the growing number of antibiotic resistance genes, or ARGs, effectively reducing antibiotics' ability to fend off diseases -- in animals and humans.

Contact: Layne Cameron
Michigan State University

Public Release: 8-Feb-2013
Combining plasma screening methods better identifies diagnostic and therapeutic targets
For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases such as diabetes, cardiovascular disease or cancer, where blood plasma has been collected. This method could vastly improve a clinician's ability to identify disease susceptibility in individuals and populations.
Deutsche Forschungsgemeinschaft

Contact: Phyllis Edelman
Genetics Society of America

Public Release: 7-Feb-2013
Surveillance system can identify and track emerging infectious diseases
A team of researchers developed a method to identify the cause of infectious disease outbreaks based on online reports about the symptoms, the season, and the ratio of cases to fatalities. Using data from the Internet outbreak reporting system ProMED-mail, the researchers applied this method to more than 100 outbreaks of encephalitis in South Asia, recently identified as an emerging infectious disease "hotspot," to determine which of 10 infectious diseases was causing symptoms of encephalitis
United States Agency for International Development

Contact: Stephanie Berger
Columbia University's Mailman School of Public Health

Public Release: 7-Feb-2013
First anti-tuberculosis medicine under USAID-supported PQM program achieves WHO prequalification
Helping to increase the availability of affordable, high-quality medicines to treat patients worldwide suffering from multi-drug resistant tuberculosis, technical assistance provided at no cost to manufacturers under the Promoting the Quality of Medicines program -- a U.S. Agency for International Development-funded program that is implemented by the U.S. Pharmacopeial Convention -- has yielded its first anti-tuberculosis medicine to achieve prequalification status from the World Health Organization.

Contact: Francine Pierson
US Pharmacopeia

Public Release: 7-Feb-2013
Lancet Infectious Diseases
New study highlights Chagas disease as a growing health and socio-economic challenge
Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas disease and found that the total economic burden of Chagas disease matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer.
Bill & Melinda Gates Foundation, Models of Infectious Disease Agent Study

Contact: Johanna Harvey
Sabin Vaccine Institute

Public Release: 6-Feb-2013
Has the 'Golden Age' of global health funding come to an end?
Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to the Institute for Health Metrics and Evaluation at the University of Washington. After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011.
Bill & Melinda Gates Foundation

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 6-Feb-2013
New England Journal of Medicine
Antibiotic cream has high cure rate, few side effects in treating cutaneous leishmaniasis
An international collaboration of researchers from the US Army Medical Research and Materiel Command, Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an investigational antibiotic cream. CL is a parasitic disease that causes disfiguring lesions, with 350 million people at risk worldwide and 1.5 million new cases annually. The results were published today in the New England Journal of Medicine.
US Army Medical Research and Materiel Command

Contact: Carey Phillips
US Army Medical Research Institute of Infectious Diseases

Public Release: 5-Feb-2013
Human bacteria sequencing project involving CU raises $340,000 online
In hopes of better understanding nutrition and health, the University of Colorado Boulder is playing the leading science role in a "crowdfunding" effort that has raised more than $340,000 for a project designed to sequence the gut bacteria of thousands of people around the world.
American Gut Project

Contact: Rob Knight
University of Colorado at Boulder

Public Release: 5-Feb-2013
Cell Metabolism
Scientists discover protein that allows safe recycling of iron from old red blood cells
Scientists have long hypothesized that our bodies must have a special protein 'container' for transporting heme -- the form of iron found in living things -- during the breakdown and recycling of old red cells and other types of heme metabolism. Now a research team led by scientists from the University of Maryland have identified this long-sought heme-iron transporter and shown that it is the same HRG1 protein found in a common microscopic worm.
National Institutes of Health

Contact: Lee Tune
University of Maryland

Public Release: 4-Feb-2013
Proceedings of the National Academy of Sciences
Injection-free vaccination technique could address global vaccine challenge for HIV, malaria
Scientists at King's College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialized immune cells in the skin to kick-start the immunizing properties of the vaccine.
Bill & Melinda Gates Foundation

Contact: Katherine Barnes
King's College London

Public Release: 1-Feb-2013
The FASEB Journal
Genetically modified tobacco plants produce antibodies to treat rabies
Smoking tobacco is bad for your health, but a genetically altered version of the plant might provide an inexpensive cure for the deadly rabies virus. In a new report in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants shown to neutralize the rabies virus. This antibody works by preventing the virus from attaching to nerve endings around the bite site and keeping the virus from traveling to the brain.

Contact: Cody Mooneyhan
Federation of American Societies for Experimental Biology

Public Release: 31-Jan-2013
UCSB anthropologists study effects of modernization on physical activity and heart disease
Heart disease continues to be the leading cause of death in the United States, and a sedentary lifestyle is often cited as a major contributing factor. Among the Tsimane, an indigenous population in the lowlands of Bolivia's Amazon basin, however, indicators of heart disease are practically non-existent –– cholesterol is low, obesity is rare, and smoking is uncommon.

Contact: Andrea Estrada
University of California - Santa Barbara

Public Release: 31-Jan-2013
PLOS Pathogens
Placental blood flow can influence malaria during pregnancy
Malaria in pregnancy causes a range of adverse effects, including abortions and stillbirths. In the latest issue of the journal PLOS Pathogen, researchers from the Instituto Gulbenkian de Ciência, Portugal, observed, for the first time, the mouse placental circulation and showed how it can influence the malaria parasite behavior and infection. Their results indicate a higher accumulation of parasites in placental regions with low blood flow, being these areas more prone to an inflammatory response.
Fundação para a Ciência e a Tecnologia

Contact: Ana Mena
Instituto Gulbenkian de Ciencia

Public Release: 31-Jan-2013
PLOS Neglected Tropical Diseases
African Programme for Onchocerciasis Control 1995-2015: Model-estimated health impact and cost
A relatively inexpensive program set up to combat river blindness has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published Jan. 31 in PLOS Neglected Tropical Diseases, shows that US $250 million helped cure or prevent the major symptoms of onchocerciasis in millions of people. In collaboration with the Management of the African Programme for Onchocerciasis Control (APOC), the researchers calculated the health impact of APOC.

Contact: Matthew Lopez

Public Release: 30-Jan-2013
Stem Cells Translational Medicine
'Petri dish lens' gives hope for new eye treatments
A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.
Australian Research Council

Contact: Emily Walker
Monash University

Public Release: 30-Jan-2013
Proceedings of the National Academy of Sciences
UNC scientists unveil a superbug's secret to antibiotic resistance
Many strains of the bacterium Staphyloccocus aureus are already resistant to all antibiotics except vancomycin. But as bacteria are becoming resistant to this once powerful antidote, S. aureus has moved one step closer to becoming an unstoppable killer. Now, researchers at the University of North Carolina at Chapel Hill have not only identified the mechanism by which vancomycin resistance spreads from one bacterium to the next, but have suggested ways to potentially stop the transfer.
National Institutes of Health

Contact: Thania Benios
University of North Carolina at Chapel Hill

Public Release: 30-Jan-2013
Journal of Neuroscience
New drug target identified for multiple sclerosis and Alzheimer's disease
Researchers at Boston University School of Medicine report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells. These findings may lead to new therapies for multiple sclerosis and Alzheimer's disease, in which white matter abnormalities are also common but have been largely ignored.

Contact: Gina DiGravio
Boston University Medical Center

Public Release: 30-Jan-2013
Lancet Neurology
Study finds parasites and poor antenatal care are main causes of epilepsy in Africa
The largest study of epilepsy in sub-Saharan Africa to date reveals that programs to control parasitic diseases and access to better antenatal care could substantially reduce the prevalence of the disease in this region.
Wellcome Trust

Contact: Jen Middleton
Wellcome Trust

Public Release: 30-Jan-2013
New England Journal of Medicine
Antibiotics cut death rate for malnourished children
Severely malnourished children are far more likely to recover and survive when given antibiotics along with a therapeutic peanut-based food than children who are simply treated with the therapeutic food alone, researchers at Washington University School of Medicine in St. Louis have found.
Hickey Family Foundation, National Institutes for Health

Contact: Elizabethe Holland Durando
Washington University School of Medicine

Showing releases 726-750 out of 888.

<< < 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 > >>